Pure Global: Singapore-Malaysia MedTech Shortcut - A New 'Two-for-One' Market Access Play.

This week, ASEAN MedTech Insights unpacks a game-changing development from March 2026: Malaysia's permanent adoption of a regulatory reliance route with Singapore. This creates a powerful "two-for-one" shortcut for medical device registration, but is it the right move for every company? We break down the massive opportunities and the hidden strategic risks of this new express lane. What if you could get your device approved in two major ASEAN markets with the effort of one? We explore the case of a company now rethinking its entire launch strategy to leverage this new Singapore-Malaysia route, and the critical questions they must answer before committing to this path. Key questions from this episode: 1. How does the "Verification Route" in Malaysia exactly work for Singapore-approved devices? 2. Which device classes are eligible for this streamlined process? 3. What are the top mistakes to avoid in your Singapore HSA submission to prevent being locked out of the Malaysian shortcut? 4. Should you always choose Singapore first, or are there times a direct-to-Malaysia approach is still better? 5. How does this reliance program affect post-market surveillance requirements in both countries? 6. What are the real timelines and fees for this new registration pathway? 7. How do you prepare a technical dossier that satisfies Singapore's high standards? Pure Global offers end-to-end regulatory consulting for MedTech companies, combining local expertise with advanced AI to streamline global market access. Whether it's developing a regulatory strategy for this new ASEAN landscape or managing your technical dossier submission, we can help. Contact us at [email protected] or visit us at https://pureglobal.com/ for tailored support.